RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 100 points on Monday.

Shares of RXO, Inc.. RXO shares rose sharply in today's pre-market trading after the company inked a definitive agreement to acquire Coyote Logistics from United Parcel Service, Inc. UPS for $1.025 billion in cash.

As per the terms, the transaction disclosed on Sunday will be financed through a combination of equity and debt, including a $300 million equity investment from MFN Partners and a $250 million equity investment from Orbis Investments, both significant shareholders of RXO.

RXO shares jumped 13.3% to $22.90 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

Alnylam Pharmaceuticals, Inc. ALNY shares gained 38.8% to $230.00 in pre-market trading after announcing topline results from its HELIOS-B Phase 3 study of vutrisiran.
Altimmune, Inc. ALT shares gained 10.9% to $7.10 in pre-market trading after the company announced that it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide at the American Diabetes Association’s 84th Scientific Sessions.
Clover Health Investments, Corp. CLOV gained 9.6% to $1.37 in pre-market trading after gaining over 21% on Friday.
argenx SE ARGX shares gained 9.9% to $433.52 in pre-market trading after the company announced the FDA approval of VYVGART Hytrulo for chronic inflammatory demyelinating polyneuropathy.
Intellia Therapeutics, Inc. NTLA shares gained 9.5% to $26.51 in pre-market trading.
Pharming Group N.V. PHAR shares gained 8.1% to $7.86 in pre-market trading after declining 8% on Friday.
Ionis Pharmaceuticals, Inc. IONS shares gained 5.2% to $44.01 in pre-market trading.